[Biguanide-induced lactacidosis in diabetic patients]. 1977

H Mehnert

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic

Related Publications

H Mehnert
November 1977, Deutsche medizinische Wochenschrift (1946),
H Mehnert
March 1977, Deutsche medizinische Wochenschrift (1946),
H Mehnert
February 1977, Die Medizinische Welt,
H Mehnert
February 1967, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten,
H Mehnert
April 1987, Clinical pharmacology and therapeutics,
H Mehnert
August 1967, Medizinische Klinik,
H Mehnert
January 1980, Die Medizinische Welt,
Copied contents to your clipboard!